KHB Unveils Advanced FOCUS PEGASUS MF200 for Veterinary Diagnostics
KHB Unveils the Advanced FOCUS PEGASUS MF200
In the ever-evolving field of veterinary diagnostics, Guangzhou Focus Biotechnology Co., Ltd., a subsidiary of KHB Group, has made a significant advancement with the launch of the FOCUS PEGASUS MF200. This state-of-the-art automatic multifunctional veterinary analyzer is designed to enhance diagnostic efficiency, reliability, and accessibility for veterinary practitioners.
The Next Generation of Diagnostic Efficiency
The FOCUS PEGASUS MF200 is a compact, all-in-one device that integrates multiple testing capabilities, including biochemical tests, electrolyte tests, coagulation tests, and immunofluorescence assays. This integration empowers veterinarians to perform a variety of diagnostics efficiently on a single platform, streamlining their workflow significantly.
One of the standout features of the device is its simplified one-step operation, which allows for rapid results in as little as 10 minutes. This capacity for rapid diagnostics meets the modern demands of veterinary practices while ensuring that animal health care providers can act swiftly in critical situations.
Advanced Technology for Enhanced Animal Care
The design of the MF200 demonstrates a commitment to animal welfare. It requires a minimal sample volume of only 100 μL, ensuring that sampling is quick, safe, and stress-free for the animals. Additionally, the intelligent system automates critical processes such as dilution, centrifugation, and QR code reading. This automation minimizes human error and ensures consistent accuracy in laboratory results.
Veterinarians will appreciate the user-friendly interface of the MF200, which simplifies operations and provides personalized reporting. This not only improves diagnostic accuracy but also enhances the daily experiences of veterinary professionals, allowing them to focus more on patient care rather than administrative tasks.
A Commitment to Innovation in Veterinary Diagnostics
KHB is dedicated to advancing intelligent veterinary diagnostics. Li Ming, the CEO of KHB Group, expressed: “The MF200 represents the next evolution in intelligent veterinary testing—a compact solution that truly redefines diagnostic efficiency.” The company aims to empower veterinary professionals to achieve speed, precision, and confidence with every test result.
After successful presentations in Asia and North America, the enhanced MF200 will now be showcased at MEDICA 2025, illustrating KHB's commitment to pioneering effective, smart, and animal-friendly diagnostics.
About KHB Group
Founded in 1981, KHB (Shanghai Kehua Bio-engineering Co., Ltd.) has grown into a high-tech enterprise specializing in a comprehensive range of medical diagnostic products. The company focuses on immunodiagnostics, biochemical diagnostics, molecular diagnostics, and point-of-care testing (POCT). KHB's dedication to research, development, manufacturing, and marketing has solidified its reputation as an industry leader, with its stock trading on the Shenzhen Stock Exchange (SZSE) since 2004. The company's subsidiary, Guangzhou Focus Biotechnology Co., Ltd., established in 2023, is dedicated to leading the veterinary diagnostics sector with innovative POCT solutions.
For more information about KHB and their offerings, visit their official website and follow them on LinkedIn, Facebook, and Twitter. For product inquiries or corporate information, contact [email protected].